Speaker illustration

Doctor Milagros Pereyra

Mayo Clinic Hospital, Phoenix (United States of America)

Impact of sodium-glucose cotransporter-2 inhibitors on survival in patients with cancer therapy-related cardiac dysfunction

Date: 1 August 2025

Journal: European Heart Journal Supplements

Thumbnail

High Lp(a) levels are a potential risk factor for aortic valve interventions in patients with bicuspid aortic valve

Date: 13 June 2024

Journal: European Journal of Preventive Cardiology

Thumbnail

ESC 365 is supported by